Chitosan (CS) derivatives are widely used in various biomedical applications due to their
unique properties like biocompatibility, mucoadhesion, non-toxicity and capability to form …

Coronary arterial disease is the most common cardiovascular disease. Myocardial ischemia-
reperfusion injury caused by the initial interruption of organ blood flow and subsequent …

Stem cell therapy is a promising therapeutic method for the treatment of ischemic heart
diseases; however, some challenges prohibit the efficacy after cell delivery due to hostile …

Biomaterials with injectability, conductivity and antibacterial effect simultaneously have been
rarely reported. Herein, we developed a new series of in situ forming antibacterial …

The development of advanced biomaterials is a crucial step to enhance the efficacy of tissue
engineering strategies for treatment of myocardial infarction. Specific characteristics of …

Cardiovascular diseases (CVD) constitute a major fraction of the current major global
diseases and lead to about 30% of the deaths, ie, 17.9 million deaths per year. CVD include …

The development of biomaterials for cardiac tissue engineering (CTE) is challenging,
primarily owing to the requirement of achieving a surface with favourable characteristics that …

Engineered cardiac patches for treating damaged heart tissues after a heart attack are
normally produced by seeding heart cells within three-dimensional porous biomaterial …

The engineering of 3-dimensional (3D) heart muscles has undergone exciting progress for
the past decade. Profound advances in human stem cell biology and technology, tissue …

Cardiac tissue damage due to myocardial infarction (MI) is one of the leading causes of
mortality worldwide. The available treatments of MI include pharmaceutical therapy, medical …